当前位置:循环首页>正文

[ACC2011]承前启后,继往开来——ACC主席Ralph G. Brindis教授畅谈大会亮点

作者:  RalphG.Brindis   日期:2011/4/6 17:23:39

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

《国际循环》: Brindis教授,你认为今年ACC会议的最突出的特点是什么?

    <International Circulation>:  Dr. Brindis, what do you think stands out this year as the most outstanding feature of the ACC conference?

   《国际循环》: Brindis教授,你认为今年ACC会议的最突出的特点是什么?

    Prof. Brindis:  I haven’t had a chance to see all of the presentations but I think the highlight of this year’s meeting is the PARTNERS trial.  Here is a situation where we are looking for new avenues and new therapies for patients with severe aortic stenosis.  We appreciate, for example, that 30-40% of patients with aortic stenosis who have the net qualifications necessary from a clinical standpoint to undergo aortic valve replacement are not having that within the United States.  There could be lots of reasons.  One being poor recognition another patient refusal, and probably also physician concern with the risks of open-heart surgery with aortic valve replacement.  Looking at new therapy such as percutaneous aortic valve implantation (TAVI) allows for an increase in our armamentarium with which to treat patients with severe aortic valve stenosis.  The study has shown us that neither surgery wins nor interventional implantation wins.  The message for me of the PARTNERS trial is that decision making and team base care utilizing cardiovascular surgeons, interventional cardiologists, treating physicians, heart failure experts, and echo cardiographers all working as a team can make individual patients decisions in order to choose the best criteria and therapy.

    Brindis教授:我还没有机会看到所有的演讲,但我认为今年的会议重点是PARTNERS研究。目前我们正在为严重的主动脉瓣狭窄患者寻求新的治疗方式和方法。我们对此表示赞赏,例如,从临床角度看,在美国主动脉瓣狭窄的患者有30%~40%有必要接受主动脉瓣置换。可能有很多原因,一个是缺乏认识;另一个是病人拒绝,还有可能是医生太关注主动脉瓣置换的开胸风险。对于治疗严重主动脉瓣狭窄患者,新的治疗方式如经皮主动脉瓣植入(TAVI)增加了我们的医疗手段。这项研究已经表明,无论介入还是手术都不是赢家。PARTNERS研究给我的提示是,利用心血管外科医师、介入心脏病学专家、内科医生、心力衰竭专家以及心脏超声学专家组成一个团队来决定治疗策略和协同治疗,根据患者个体做出决定以便选择最佳的标准和治疗方案。

[1]  [2]  [3]  [4]  下一页

版面编辑:沈会会  责任编辑:张衡



ACC大会亮点PARTNERS研究医疗改革医患关系华法林

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530